首页> 外文OA文献 >Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?

【2h】

Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?

机译：哪种喉部保存策略将最适合具有可重型，局部晚期的低噬细胞癌癌的患者？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Nora Sobrevilla-Moreno; Javier Altamirano-Garcia; Martin Granados-Garcia; Alexandra Garcilazo-Reyes; MArytere Herrera-Martinez; Miguel Alvarez-Avitia;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. EORTC 24051: Unexpected side effects in a phase i study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma [J] . Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2012 ,第2期

机译：EORTC 24051：在局部晚期可切除的喉和下咽鳞状细胞癌患者中，TPF诱导化学疗法随后用拉帕替尼（一种EGFR / ErbB2双重抑制剂）进行化学放疗的I期研究中出现了意外的副作用
2. 2-(18F)-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. [J] . Roh JL, Pae KH, Choi SH, European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2007 ,第6期

机译：2-（18F）-氟-2-脱氧-D-葡萄糖正电子发射断层扫描作为晚期可切除的喉和下咽鳞状细胞癌患者的主要治疗指导。
3. Clinical implication of computed tomography findings in patients with locally advanced squamous cell carcinoma of the larynx and hypopharynx [J] . Ryu In Sun, Lee Jeong Hyun, Roh Jong-Lyel, European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) . 2015 ,第10期

机译：CT扫描在喉及下咽部局部晚期鳞状细胞癌患者中的临床意义
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck. [D] . Wirth, Pamela Susan. 2010

机译：表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
6. A PHASE II TRIAL OF SURGERY WITH PERIOPERATIVE INGN 201 (Ad5CMV-p53) GENE THERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR ADVANCED RESECTABLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY OROPHARYNX HYPOPHARYNX AND LARYNX: REPORT OF THE SOUTHWEST ONCOLOGY GROUP [O] . George H. Yoo, James Moon, Michael LeBlanc, -1

机译：围手术期INGN外科杂志II期试验201（ad5CmV-p53基因）基因治疗随后放化疗aDVaNCED口腔口咽下咽和喉可切除鳞状细胞癌：西南肿瘤组的报告
7. Patterns of regional lymph node failure of locally advanced hypopharynx squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy [O] . Dongqing Wang, Shui Yu, Liming Zhai, 2019

机译：用手术和/或强度调制放疗局部治疗后局部晚期后咽鳞状细胞癌的区域淋巴结失效的模式

Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?

著录项

相似文献

相关主题

期刊订阅